Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review.

Publication Year: 2024

DOI:
10.3803/EnM.2023.1794

PMCID:
PMC10901657

PMID:
38417830

Journal Information

Full Title: Endocrinol Metab (Seoul)

Abbreviation: Endocrinol Metab (Seoul)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported."

Evidence found in paper:

"This study was supported by the Korean Thyroid Association and research funding from the National Cancer Center (grant number 2112570-3)."

Evidence found in paper:

"We conducted a literature search of the Cochrane Library, Elsevier Embase, KoreaMed, and Ovid MEDLINE databases up to March 2023. The search terms used were [(active surveillance OR observation)] AND [(papillary thyroid microcarcinoma) OR (thyroid cancer)]. All articles included in this review are written in English. We reported this systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines () and registered it at the International Prospective Register of Systematic Reviews (PROSPERO; CRD42022352144) []. Prisma checklist was presented in ."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025